ArriVent BioPharma, Inc.
Company Stats
- Market Cap
- $1.5B
- as of Sep 30, 2026
- Shares Outstanding
- 49.3M
- Free Float
- 70.0%
Income Statement
- Operating Income
- -$177.5M
- Net Income
- -$166.3M
- EBITDA
- -$174.5M
Balance Sheet
- Cash & Equivalents
- $45.5M
Returns & Capital
- SBC, 3Y Avg
- $5.5M
Annual filing data through FY ended December 31, 2025; shares and float as of October 6, 2026. Yields and enterprise value use the calculated market cap above, at its as-of date. Ratios are our calculations from reported figures.
Stronger demand supports expansion as pricing diverges